Rigel Pharma (RIGL) Misses Q2 EPS by 1c

Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge